Erica Peters, MD
Internal Medicine · Atlanta, GANPI 1225152044
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $281 and has fallen 51.8% since, to $136 in 2024.
Across 25 payments — averaging $18.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$89
- GSK$72
- Pfizer$63
- Exact Sciences$52
- AbbVie$43
- Boehringer Ingelheim$33
- plus $123 from 6 others
What the payments were for
- Food & beverage$474100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 6 | $89 |
| GSK | 4 | $72 |
| Pfizer | 3 | $63 |
| Exact Sciences | 3 | $52 |
| AbbVie | 2 | $43 |
| Boehringer Ingelheim | 1 | $33 |
| Novartis | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| AstraZeneca | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Dynavax Technologies Corporation | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
How this compares
$474 in reported general payments places this provider in the 55th percentile of 3,311 internal medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 72 | $691 |
| Metformin Hcl ErMetformin Hcl | 31 | $592 |
| Duloxetine Hcl | 18 | $558 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 24 | $512 |
| Rosuvastatin Calcium | 59 | $505 |
| Levothyroxine Sodium | 43 | $472 |
| Bupropion XlBupropion Hcl | 14 | $444 |
| Amlodipine Besylate | 37 | $281 |
| Trazodone Hcl | 25 | $277 |
| Losartan Potassium | 17 | $248 |
| Pantoprazole Sodium | 18 | $214 |
| Escitalopram Oxalate | 12 | $201 |
| Sertraline Hcl | 24 | $163 |
| Lisinopril | 24 | $141 |
| Metformin Hcl | 17 | $101 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Atlanta
- Tracey HenryAtlanta$305K
- Scott ParryAtlanta$162K
- Jennifer GilliganAtlanta$162K
- Tanna LimAtlanta$88K
- Sally IwamotoAtlanta$60K
- Antoine TrammellAtlanta$33K
- Samuel AdamsAtlanta$30K
- Jamal HajjariAtlanta$29K
- Carlos SaldanaAtlanta$25K
- Michael HicksonAtlanta$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.